Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
ALTO-203 by Alto Neuroscience for Major Depressive Disorder: Likelihood of Approval
ALTO-203 is under clinical development by Alto Neuroscience and currently in Phase II for Major Depressive Disorder. According to GlobalData,...